[1] ESPOSITO S, ARGENTIERO A, GRAMEGNA A, et al.Mycoplasma pneumoniae: a pathogen with unsolved therapeutic problems[J].Expert Opin Pharmacother, 2021, 22(9): 1193-1202. [2] CHO HK. Consideration in treatment decisions for refractory Mycoplasma pmneumoniae pneumonia[J]. Clin Exp Pediatr, 2021, 64(9):459.467. [3] 关敏, 白雪梅. 几种常见炎症因子在小儿重症肺炎支原体肺炎中的临床意义[J].中国小儿急救医学, 2020, 27(5):371-374. [4] 付彬彬, 钟兰兰, 叶婷婷, 等.Autotaxin对儿童难治性肺炎支原体肺炎的预测价值及其与炎性细胞因子的相关性[J]. 中国当代儿科杂志, 2022, 24(7):765-770. [5] 中华医学会儿科学分会临床检验学组.儿童肺炎支原体呼吸道感染实验室诊断中国专家共识[J].中华检验医学杂志, 2019, 42(7):507-513. [6] 曹宪振, 马杰彦, 胡亮, 等.2108例儿童呼吸道病原体感染的流行病学特征[J/CD].新发传染病电子杂志, 2024, 9(1):12-16. [7] NIKITOPOULOU I, FANIDIS D, NTATSOULIS K, et al.Increased autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells[J]. Int J Mol Sci, 2021, 22(18):10006. [8] 马帅, 温浦钲, 康丽惠, 等.儿童肺炎支原体肺炎的临床及影像学特征分析[J/CD].新发传染病电子杂志, 2024, 9(1):7-11. [9] 万钟予, 戚惠霏, 卢燕鸣.肺部超声评分联合外周血参数比值在儿童重症肺炎支原体肺炎中的意义[J]. 临床肺科杂志, 2023, 28(10):1505-1510. [10] 刘峰. 难治性肺炎支原体肺炎的预测因素[J].中华实用儿科临床杂志, 2021, 36(16): 55-59. [11] AHMADI Z, HASSANSHAHI G, KHORRAMDELAZAD H, et al.An overlook to the characteristics and roles played by eotaxin network in the pathophysiology of food allergies: allergic asthma and atopic dermatitis[J]. Inflammation, 2016, 39(3):1253-1267. [12] MAES T, BRUSSELLE GG.Simultaneous inhibition of thymic stromal lymphopoietin, IL-33 and IL 25: a therapeutic option in asthma?[J]. Respirology, 2020, 25(6):566-567. [13] YAMAYA M, NOMURA K, ARAKAWA K, et al.Clarithromyein decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma; effects on IL-6, IL-8 and IL-33[J]. Arch Pharm Res, 2020, 43(5):526-539. [14] 崔小健, 张嘉懿, 郭文伟, 等.儿童难治性肺炎支原体肺炎的临床特征和高危因素预测[J]. 重庆医学, 2020, 49(17):2905-2908, 2912. |